Cravo M, Pinto R, Fidalgo P, Chaves P, Glória L, Nobre-Leitão C, Costa Mira F
Serviço de Gastrenterologia, Instituto Português de Oncologia, Francisco Gentil, Lisbon, Portugal.
Gut. 1996 Sep;39(3):434-8. doi: 10.1136/gut.39.3.434.
Global DNA hypomethylation has been found in the premalignant stages of some neoplasms and has been implicated as an important factor for tumour progression.
The aim of this study was to evaluate whether DNA hypomethylation occurs during the process of gastric carcinogenesis.
Gastric specimens were obtained from 49 patients and histologically classified as: normal 10, superficial gastritis 14, chronic atrophic gastritis with intestinal metaplasia 15, and intestinal type of gastric carcinoma 10. Global DNA methylation was assessed by incubating DNA with (3H)-S-adenosylmethionine and Sss1 methylase. A higher incorporation of (3H) methyl groups reflects a lower degree of intrinsic methylation.
A graduated increase in (3H) methyl group incorporation into DNA was found over the range extending from normal gastric mucosa, to superficial gastritis and to chronic atrophic gastritis (136,556 (24,085) v 235,725 (38,636) v 400,998 (26,747 dpm/micrograms/DNA respectively; p = 0.0002). No further increase was found in specimens from patients with carcinoma. No differences were found between extent of DNA methylation in neoplastic or non-neoplastic mucosa from patients with gastric carcinoma. Hypomethylation of DNA increased substantially with severe atrophy (p = 0.01) or with type III intestinal metaplasia (p = 0.15).
Global DNA hypomethylation occurs in the early stages of gastric carcinogenesis, and it may be a novel biomarker of gastric neoplasia, useful in monitoring the response to chemopreventive agents.
在某些肿瘤的癌前阶段已发现全基因组DNA低甲基化,并被认为是肿瘤进展的重要因素。
本研究旨在评估DNA低甲基化是否发生在胃癌发生过程中。
从49例患者获取胃标本,组织学分类为:正常10例、浅表性胃炎14例、慢性萎缩性胃炎伴肠化生15例、肠型胃癌10例。通过将DNA与(3H)-S-腺苷甲硫氨酸和Sss1甲基转移酶孵育来评估全基因组DNA甲基化。(3H)甲基基团掺入量越高,反映内在甲基化程度越低。
从正常胃黏膜到浅表性胃炎再到慢性萎缩性胃炎,发现DNA中(3H)甲基基团掺入量逐渐增加(分别为136,556(24,085)、235,725(38,636)、400,998(26,747)dpm/微克/DNA;p = 0.0002)。癌患者标本中未发现进一步增加。胃癌患者肿瘤性或非肿瘤性黏膜的DNA甲基化程度无差异。DNA低甲基化随着严重萎缩(p = 0.01)或III型肠化生(p = 0.15)而显著增加。
全基因组DNA低甲基化发生在胃癌发生的早期阶段,它可能是胃癌的一种新型生物标志物,有助于监测对化学预防剂的反应。